Inventor
Nicholas CALANDRA
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07DHeterocyclic compounds14%
C07KPeptides14%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms14%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
C07CAcyclic or carbocyclic compounds7%
PatentTitleYear
12,514,926Splicing modulator antibody-drug conjugates and methods of use202612,275,696Process for preparing tapinarof202512,172,986Splicing modulator antibody-drug conjugates and methods of use202411,945,807Splicing modulator antibody-drug conjugates and methods of use202411,597,692Process for preparing tapinarof202311,352,348Splicing modulator antibody-drug conjugates and methods of use2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to EISAI R&D MAN CO LTD (4)· patent assignee history
2022–2026Based in US· patent location history
2023–2025Patents assigned to Dermavant Sciences GmbH (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| EISAI R&D MAN CO LTD | 4 | 2022–2026 |
| Dermavant Sciences GmbH | 2 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2026 |